FDA Advisory Committee Votes To Make Peptides More Available: What You Need To Know

If you are an advocate of peptides, as we are at Phase Longevity, you have probably heard about a highly anticipated FDA advisory committee meeting held on July 23 and 24, 2026, to consider expanding access. The committee voted to recommend that 6 peptides be “whitelisted” for compounding pharmacies and one denied. So what does this mean for prescribers, consumers, and pharmacies? The short answer is it’s a small step in the right direction, but for now nothing changes, and they remain in a regulatory gray area. 

What You Need To Know

The peptides voted for whitelisting are:

• BPC-157 – promotes tissue repair and gut health
• KPV- anti-inflammatory peptide often combined with BPC-157
• TB-500 – based on thymosin beta 4, promotes systemic healing; often combined with BPC-157 (“wolverine stack”); banned in competitive sports by the World Anti-Doping Agency (WADA)
• MOTS-c – mitochondrial peptide involved in cellular energy regulation; enhances response to exercise; may be helpful for PMOS (formerly PCOS); also banned by WADA
• Epitalon – synthetic peptide intended to promote circadian regulation, telomeres, and immune support
• Semax – synthetic peptide used to enhance cognition and promote neuroplasticity; developed (and approved) in Russia for recovery from stroke and memory impairment

FDA Whitelist Does Not Mean Approval

The FDA whitelist, technically called the 503A bulks list, is a catalog of drugs that compounding pharmacies are allowed to produce and distribute. Being on the whitelist does not mean that the drug is approved (peptides are technically drugs), and the committee’s vote was only advisory. The FDA is under no obligation to honor the committee’s recommendation, and their position has historically been that tighter restrictions on these and other peptides should remain until there is more evidence of safety and efficacy from clinical studies. I don’t know how this will play out, but we’re hoping for a reasonable compromise somewhere between unfettered access to drugs of undocumented purity, safety, and unproven efficacy on one side, and the opposite extreme of unnecessarily heavy-handed restrictions on the other.

Be Smart About Peptides for Best Results

Right now, people are self-injecting “research grade” peptides from China sourced from wellness influencers, gym owners, and online storefronts, with minimal, if any, oversight or guidance from a medical professional. Why anyone would inject something that says “not for human use” right on the label is beyond me. However, the FDA’s position against allowing these peptides to be available could be what drove people to alternative and questionable sources. While the recommended peptides are generally safe, life-threatening adverse reactions have occurred, and it doesn’t make sense to me to have them available without a medical professional available to manage potential side effects, adjust dosing when needed, and track results. This requires lab tests and ideally an in-person physical exam. I’m not convinced that a 5-minute telemedicine call is sufficient.   

Contact Us To Learn More About the Impact of This Vote

In the coming months to years, there will be a lengthy rulemaking process, ongoing debate, and political influence. In the meantime, many peptides continue to be legally available, but if we aren’t smart about it, that could change.

For more information about these and other peptides, contact us.